FDA Approves Agilent's PD-L1 IHC 22C3 pharmDx for Gastric Adenocarcinoma

Agilent  announced that it has received FDA approval for the use of PD-L1 IHC 22C3 pharmDx as a diagnostic tool to aid in identifying patients with Ga...

November 29, 2023 | Wednesday | News
Seegene Boosts ESG Rating by Korea Institute of Corporate Governance and Sustainability

Seegene Inc. (KQ096530), a leading South Korean company providing a total solution for PCR molecular diagnostics, announced on November 10 that it has rece...

November 24, 2023 | Friday | News
CMI Inc. and Life Molecular Imaging Secure Reimbursement for Amyloid-PET Diagnostic Neuraceq® in Japan

CMI Inc. and Life Molecular Imaging (LMI) are pleased to announce that the amyloid-PET diagnostic  Neuraceq® (florbetaben 18F injection) has ...

November 23, 2023 | Thursday | News
Bracco's Strategic Partnership with ulrich medical for Syringeless MRI Injectors

Bracco, a global leader in diagnostic imaging, and ulrich GmbH & Co. KG, a renowned German medical device manufacturer specializing in contrast media i...

November 23, 2023 | Thursday | News
GE Healthcare Launches Enhanced Digital Expert Access for Remote Patient Scans, Secures Exclusive Distribution Deal with IONIC Health

GE HealthCare (Nasdaq: GEHC) has received U.S. FDA 510(k) Clearance for the new version of Digital Expert Access with remote scanning, the first remote pat...

November 22, 2023 | Wednesday | News
10x Genomics Wins Another Patent Infringement Case Against NanoString Technologies

GeoMx Decision is Third Ruling Against NanoString, Showing Serial Infringement of 10x Patents 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell an...

November 20, 2023 | Monday | News
Route 92 Medical Secures $31M in Series F Funding to Boost Expansion in Growing Stroke Treatment Market

The oversubscribed capital raise was led by existing venture capital investors: U.S. Venture Partners, Norwest Venture Partners, InnovaHealth Partners, and...

November 17, 2023 | Friday | News
Vertex and CRISPR Therapeutics Granted Historic Approval for CASGEVY™, the World's First CRISPR/Cas9 Gene-Edited Therapy, by UK MHRA to Combat Sickle Cell Disease and Beta Thalassemia

 - First regulatory authorization of a CRISPR-based gene-editing therapy in the world – - CASGEVY is indicated for the treatment of sickle cell...

November 17, 2023 | Friday | News
Lilly Receives NRC Consent for POINT Biopharma Acquisition

Eli Lilly and Company (NYSE: LLY)  announced that the U.S. Nuclear Regulatory Commission ("NRC") has issued its consent for the indirect transfer...

November 15, 2023 | Wednesday | News
FDA Clears Solid Biosciences' Gene Therapy for Duchenne Muscular Dystrophy

Planning to initiate Phase 1/2 trial in pediatric DMD Patients – – First cohort to study patients 4 to < 6 years of age –   &l...

November 15, 2023 | Wednesday | News
Hepion Pharmaceuticals Reports Significant Liver Stiffness Reduction in Advanced MASH Liver Disease Study

Demonstrated improvements among best reported of fibrosis-reducing compounds - - Liver stiffness results complemented by positive changes in disease bioma...

November 14, 2023 | Tuesday | News
STADA, Alvotech Get Positive CHMP Nod for Europe's First Ustekinumab Biosimilar to Stelara

Positive CHMP opinion for Uzpruvo biosimilar is based on comprehensive package comprising analytical, non-clinical and clinical similarity data, includin...

November 13, 2023 | Monday | News
FDA Approves First Vaccine to Prevent Disease Caused by Chikungunya Virus

The chikungunya virus is primarily transmitted to people through the bite of an infected mosquito. Chikungunya is an emerging global health threat with at ...

November 10, 2023 | Friday | News
FDA Prioritizes Bristol Myers Squibb's Breyanzi for CLL/SLL Review

Application based on results from TRANSCEND CLL 004, the first pivotal multicenter trial to show clinical benefit with a CAR T cell therapy in heavil...

November 10, 2023 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close